Dynamic Advisor Solutions LLC Trims Stock Position in Synopsys, Inc. $SNPS

Dynamic Advisor Solutions LLC decreased its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 52.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,200 shares of the semiconductor company’s stock after selling 1,347 shares during the quarter. Dynamic Advisor Solutions LLC’s holdings in Synopsys were worth $592,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of SNPS. Brighton Jones LLC grew its holdings in Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares during the period. Compound Planning Inc. boosted its holdings in shares of Synopsys by 45.7% in the 1st quarter. Compound Planning Inc. now owns 746 shares of the semiconductor company’s stock valued at $320,000 after purchasing an additional 234 shares during the last quarter. Kestra Advisory Services LLC grew its stake in shares of Synopsys by 3.0% during the 1st quarter. Kestra Advisory Services LLC now owns 5,572 shares of the semiconductor company’s stock valued at $2,390,000 after buying an additional 161 shares during the period. ICONIQ Capital LLC increased its holdings in shares of Synopsys by 38.6% during the 1st quarter. ICONIQ Capital LLC now owns 639 shares of the semiconductor company’s stock worth $274,000 after buying an additional 178 shares during the last quarter. Finally, Comerica Bank increased its holdings in shares of Synopsys by 10.8% during the 1st quarter. Comerica Bank now owns 34,197 shares of the semiconductor company’s stock worth $14,665,000 after buying an additional 3,324 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on SNPS. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. The Goldman Sachs Group reduced their price objective on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. BNP Paribas assumed coverage on shares of Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price for the company. Rosenblatt Securities upgraded shares of Synopsys from a “neutral” rating to a “buy” rating and cut their price target for the company from $605.00 to $560.00 in a report on Tuesday, December 9th. Finally, Morgan Stanley boosted their price objective on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Eleven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $562.13.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.62% of the stock is owned by corporate insiders.

Synopsys Stock Performance

Synopsys stock opened at $481.24 on Tuesday. The firm has a market capitalization of $89.39 billion, a PE ratio of 60.23, a price-to-earnings-growth ratio of 3.86 and a beta of 1.16. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The stock’s 50 day moving average price is $434.86 and its 200 day moving average price is $504.21. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter last year, the company earned $3.40 earnings per share. Synopsys’s revenue for the quarter was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Large institutional buying and favorable analyst coverage: recent filings show big quarter‑end additions by Vanguard, Morgan Stanley and BlackRock, and multiple recent buy/overweight ratings with a median price target near $570 — support that can underpin the share rally and liquidity. QuiverQuant: SNPS Opinions (Institutional / Analyst Activity)
• Neutral Sentiment: Social/media chatter about a reported $2 billion Nvidia investment into Synopsys is circulating and fueling optimism about AI/chip‑design synergies — but this appears to be unconfirmed rumor-level chatter; if verified it would be a major positive, otherwise it’s speculative. QuiverQuant: Nvidia investment buzz
• Negative Sentiment: Multiple law firms have filed notices and are soliciting SNPS shareholders for a securities‑class action covering purchases between Dec 4, 2024 and Sep 9, 2025 (lead‑plaintiff deadlines around Dec 30, 2025). The filings allege securities‑law violations tied to a sharp post‑Sept 9 decline — increased litigation risk can pressure the stock and create ongoing headline risk. GlobeNewswire: Lost Money on Synopsys? Join Class Action
• Negative Sentiment: Insider selling: CFO Shelagh Glaser sold 3,657 shares on Dec. 19 at about $460.77 (reducing her stake ~17%). Insider sales can be viewed as a near‑term negative signal even if routine; investors often watch such moves while litigation headlines are active. SEC filing – Insider Sale (Shelagh Glaser)

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.